Publication Date:
2015-02-07
Description:
Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy Blood Cancer Journal 5, e278 (February 2015). doi:10.1038/bcj.2014.95 Authors: Z R Chalmers, S M Ali, R S Ohgami, P V Campregher, G M Frampton, R Yelensky, J A Elvin, N A Palma, R Erlich, J-A Vergilio, J Chmielecki, J S Ross, P J Stephens, R Hermann, V A Miller & C R Miles
Electronic ISSN:
2044-5385
Topics:
Medicine
Permalink